Silva Pharmaceuticals Limited (DSE:SILVAPHL)

Bangladesh · Delayed Price · Currency is BDT

16.80

-0.10 (-0.59%)

At close: Jul 23, 2026

48.67% (1Y)

Market Cap	2.22B +48.2%
Revenue (ttm)	329.63M -23.6%
Net Income	-154.19M
EPS	-1.13
Shares Out	136.50M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,178,459
Open	16.80
Previous Close	16.90
Day's Range	16.70 - 17.20
52-Week Range	7.60 - 17.80
Beta	-0.07
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 26, 2026

About Silva Pharmaceuticals

Silva Pharmaceuticals Limited engages in manufacturing and marketing of pharmaceuticals finished products in Bangladesh and internationally. The company offers drugs for various categories, including antibiotics, analgesics, anti-diabetics, narcotics, anti-pyretics, anti-inflammatory, anti ulcerants, antiemetic, gastroprokinetic, antihistamine, anti-spasmodic expectorants, and vitamins and mineral. It also provides pharmaceutical products in therapeutic areas, such as anemias and other blood disorders, central nervous system, gastro- intestinal... [Read more]

Industry Pharmaceutical Preparations

Founded 2001

Employees 678

Stock Exchange Dhaka Stock Exchange

Ticker Symbol SILVAPHL

Full Company Profile

Financial Performance

In fiscal year 2025, Silva Pharmaceuticals's revenue was 383.65 million, a decrease of -36.02% compared to the previous year's 599.66 million. Losses were -132.95 million, 106.2% more than in 2024.

Financial Statements